Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05101070 |
Title | S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors (aCCeleR8-001) |
Acronym | aCCeleR8-001 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Shionogi Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Angeles Clinic and Research Center | RECRUITING | Los Angeles | California | 90025 | United States | Details |
Henry Ford Health Center | RECRUITING | Detroit | Michigan | 48202 | United States | Details |
Fox Chase Cancer Center | RECRUITING | Philadelphia | Pennsylvania | 19111 | United States | Details |
National Cancer Center Hospital East | RECRUITING | Kashiwa | Chiba | Japan | Details | |
Osaka University Hospital | RECRUITING | Suita | Osaka | Japan | Details | |
National Cancer Center Hospital | RECRUITING | Chuo Ku | Tokyo | Japan | Details |